Johnson & Johnson (J&J) India has introduced a nationwide campaign, India Detects to Defeat, aimed at emphasising the importance of early detection and testing to improve lung cancer outcomes. As part of its first phase, the campaign features a collaboration with Amar Chitra Katha to create an illustrated booklet simplifying complex medical information.
The booklet, available in both print and digital formats, is designed to help patients and their families understand the risks, symptoms, and significance of early diagnosis for lung cancer. It can be accessed at selected healthcare provider clinics or via the J&J India website.
The Indian Council of Medical Research (ICMR) projects a significant rise in lung cancer cases, anticipating a seven-fold increase by 2025. In 2022, India reported approximately 81,000 lung cancer cases and 75,000 deaths, making it one of the leading causes of cancer-related mortality.
The India Detects to Defeat campaign focuses on Non-Small Cell Lung Cancer (NSCLC), which accounts for 85 per cent of lung cancer cases globally, according to The Lancet Regional Health – Southeast Asia. NSCLC is often linked to genetic mutations, such as those involving the epidermal growth factor receptor (EGFR) gene, which contributes to uncontrolled cell growth.
Pushkar Kulkarni, who heads Johnson & Johnson Innovative Medicine India & South Asia operations, highlighted the significance of the initiative, stating, “Partnering with Amar Chitra Katha in the first phase of the ‘India Detects to Defeat’ campaign, lets us spread lung cancer awareness in a way that’s both accessible and memorable. Through storytelling, we simplify complex information, reaching families across India and empowering them to recognise early signs and seek timely care. This booklet is our call to action: know the signs, seek early diagnosis, consult your physician for guidance, and take a stand against this silent killer. Together, we can make a real impact on early detection and save lives.”
Gayathri Chandrasekhar, Editor-in-Chief of Amar Chitra Katha, added, “At Amar Chitra Katha, we believe in the power of stories to inspire, educate, and bring positive change. This partnership helps us reach a broader audience, delivering a complex health message simply. Through relatable narratives, we hope to spark conversations around lung health and early detection, empowering families to make informed health decisions.”
According to the World Health Organization, lung cancer is the leading cause of cancer-related deaths globally, with high mortality rates among both men and women. The disease is often diagnosed at advanced stages when treatment options are limited. Screening high-risk individuals offers the potential for early detection and improved survival rates.
The campaign represents a focused effort to bridge the gap in awareness about lung cancer and encourage timely action to address its impact.